GYS2 and hepatocellular carcinoma: Remarkably, Fig 4D shows that in The Cancer Genome Atlas (TCGA) liver cancer (HCC) cohort, high expression of Wnt/β-catenin targets strongly anti-correlated with GYS2 expression.